Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Feb 1;29(3):235-46.
doi: 10.1111/j.1365-2036.2008.03885.x. Epub 2008 Nov 8.

Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis

A K Waljee  1 , M J Dimagno, B U Wu, P S Schoenfeld, D L Conwell
Affiliations

Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis

A K Waljee et al. Aliment Pharmacol Ther. .

Abstract

Background: Pancreatic enzyme supplementation is standard treatment for malabsorption caused by chronic pancreatitis. The FDA recently required all manufacturers to submit New Drug Applications to continue to market these agents because published data demonstrated variation in formulation, bioavailability and shelf-life while providing limited data about efficacy and safety.

Aim: To review systematically the design and results of randomized, parallel-design trials of pancreatic enzyme supplements in chronic pancreatitis patients with steatorrhea.

Methods: A computer-assisted search of MEDLINE and EMBASE was performed to identify relevant studies. Two authors performed duplicate data extraction on study design, improvement in coefficient of fat absorption (CFA), diarrhoea and adverse events using pre-specified forms. Agreement between investigators for data extraction was greater than 95%.

Results: Of 619 articles found through literature searching, 20 potentially relevant articles were identified and four manuscripts met inclusion criteria. No studies performed head-to-head comparisons of different supplements. Enzyme supplementation is more likely to improve CFA compared with placebo, but fat malabsorption remained abnormal. Important differences in patient population, study endpoint, study design, pancreatic enzyme dosage and measurement of CFA were present across trials, which precluded comparison of different agents.

Conclusions: Enzyme supplementation improves CFA compared to placebo, but may not abolish steatorrhoea.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis
See this image and copyright information in PMC

References

    1. Tang C, Biemond I, Lamers CB. Cholecystokinin receptors in human pancreas and gallbladder muscle: a comparative study [see comments] Gastroenterology. 1996;111(6):1621–6. - PubMed
    1. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology. 2001;120(3):682–707. - PubMed
    1. Raimondo M, Wallace MB. Diagnosis of early chronic pancreatitis by endoscopic ultrasound. Are we there yet? JOP. 2004;5(1):1–7. - PubMed
    1. Axon AT, et al. Pancreatography in chronic pancreatitis: international definitions. Gut. 1984;25(10):1107–12. - PMC - PubMed
    1. Mullhaupt B, Truninger K, Ammann R. Impact of etiology on the painful early stage of chronic pancreatitis: a long-term prospective study. Z Gastroenterol. 2005;43(12):1293–301. - PubMed

Publication types

MeSH terms